Nanoparticle injection reprograms NK immune cells to fight cancer and autoimmune disorders

MIT engineers have developed a new method to program natural killer (NK) immune cells to target cancerous T cells or T cells that have become autoreactive, leading to diseases such as lymphoma and autoimmune hepatitis. This could potentially revolutionize cancer and autoimmune disorder treatments.